Literature DB >> 31664480

Mechanism and biomarkers in aortitis--a review.

Benjamin Benhuri1,2, Ammar ELJack1,3, Bashar Kahaleh4, Ritu Chakravarti5.   

Abstract

Aortitis can be the manifestation of an underlying infectious or noninfectious disease process. An autoimmune cause is suggested in a large proportion of noninfectious causes. Similar to other autoimmune diseases, the pathophysiology of aortitis has been investigated in detail, but the etiology remains unknown. Most cases of aortitis often go undetected for a long time and are often identified at late stages of the disease. Recent advances in imaging techniques have significantly improved the diagnosis of aortitis. However, significant challenges associated with the imaging techniques limit their use. Several routine inflammation-based markers, such as erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), and inflammatory cytokines, are nonspecific and, therefore, have limited use in the diagnosis of aortitis. The search for more specific serum biomarkers, which can facilitate detection and progression is under progress. Several autoantibodies have been identified, but assigning their role in the pathogenesis as well as their specificity remains a challenge. The current review addresses some of these issues in detail. KEY MESSAGES: • Noninfectious aortitis is an autoimmune disease. • Several biomarkers, including cytokines and autoantibodies, are increased in aortitis. • Imaging techniques, commonly used to detect aortitis, are associated with the high cost and technical challenges. • There is a need to develop low-cost biomarker-based detection tools. • The knowledge of biomarkers in aortitis detection is discussed.

Entities:  

Keywords:  14-3-3zeta; Aortitis; Autoantibody; Autoantigen; Biomarker; Inflammation

Mesh:

Substances:

Year:  2019        PMID: 31664480     DOI: 10.1007/s00109-019-01838-1

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  155 in total

1.  Association of NOS2 and potential effect of VEGF, IL6, CCL2 and IL1RN polymorphisms and haplotypes on susceptibility to GCA--a simultaneous study of 130 potentially functional SNPs in 14 candidate genes.

Authors:  Anna Enjuanes; Yolanda Benavente; José Hernández-Rodríguez; Carme Queralt; Jordi Yagüe; Pedro Jares; Silvia de Sanjosé; Elias Campo; Maria C Cid
Journal:  Rheumatology (Oxford)       Date:  2012-01-17       Impact factor: 7.580

Review 2.  Aortitis.

Authors:  Heather L Gornik; Mark A Creager
Journal:  Circulation       Date:  2008-06-10       Impact factor: 29.690

Review 3.  Outcome assessment in Takayasu arteritis.

Authors:  Daiki Nakagomi; David Jayne
Journal:  Rheumatology (Oxford)       Date:  2015-10-15       Impact factor: 7.580

4.  Serum amyloid A concentrations in giant-cell arteritis and polymyalgia rheumatica: a useful test in the management of the disease.

Authors:  E Hachulla; R Saile; H J Parra; P Y Hatron; D Gosset; J C Fruchart; B Devulder
Journal:  Clin Exp Rheumatol       Date:  1991 Mar-Apr       Impact factor: 4.473

5.  Association of ferritin autoantibodies with giant cell arteritis/polymyalgia rheumatica.

Authors:  N T Baerlecken; A Linnemann; W L Gross; F Moosig; T R Vazquez-Rodriguez; M A Gonzalez-Gay; J Martin; I Kötter; J C Henes; I Melchers; P Vaith; R E Schmidt; T Witte
Journal:  Ann Rheum Dis       Date:  2012-01-05       Impact factor: 19.103

6.  Cytokine mRNA repertoire of peripheral blood mononuclear cells in Takayasu's arteritis.

Authors:  N Kumar Tripathy; S Kumar Chauhan; S Nityanand
Journal:  Clin Exp Immunol       Date:  2004-11       Impact factor: 4.330

Review 7.  Diagnosis, Management, and Outcome of Aortitis at a Single Center.

Authors:  Nedaa Skeik; Claire A Ostertag-Hill; Ross F Garberich; Peter B Alden; Jason Q Alexander; Andrew H Cragg; Jesse M Manunga; Elliot J Stephenson; Jessica M Titus; Timothy M Sullivan
Journal:  Vasc Endovascular Surg       Date:  2017-08-31       Impact factor: 1.089

8.  An uneven expression of T cell receptor V genes in the arterial wall and peripheral blood in giant cell arteritis.

Authors:  C Schaufelberger; R Andersson; E Nordborg; G K Hansson; C Nordborg; J Wahlström
Journal:  Inflammation       Date:  2008-12       Impact factor: 4.092

9.  Is vascular endothelial growth factor a useful biomarker in giant cell arteritis?

Authors:  Nicola Goodfellow; Julien Morlet; Surjeet Singh; Afsie Sabokbar; Andrew Hutchings; Vanshika Sharma; Jana Vaskova; Shauna Masters; Allahdad Zarei; Raashid Luqmani
Journal:  RMD Open       Date:  2017-03-29

10.  Serum Cytokine Profile in Asian Indian Patients with Takayasu Arteritis and its Association with Disease Activity.

Authors:  Ruchika Goel; Jayakanthan Kabeerdoss; Babu Ram; John Antony Jude Prakash; Sudhir Babji; Aswin Nair; Lakshmanan Jeyaseelan; Visalakshi Jeyaseelan; John Mathew; Veeraraghavan Balaji; George Joseph; Debashish Danda
Journal:  Open Rheumatol J       Date:  2017-02-28
View more
  6 in total

Review 1.  Aortitis - An Interdisciplinary Challenge.

Authors:  Tetyana Shchetynska-Marinova; Klaus Amendt; Maliha Sadick; Michael Keese; Martin Sigl
Journal:  In Vivo       Date:  2021 Jan-Feb       Impact factor: 2.155

2.  Aortitis as a Harbinger of Esophageal Cancer.

Authors:  Sandra Ganchinho Lucas; Filipe Alfaiate; Inês Santos; Rita Rocha; Ireneia Lino
Journal:  Cureus       Date:  2021-11-30

3.  14-3-3ζ-TRAF5 axis governs interleukin-17A signaling.

Authors:  Jenna McGowan; Cara Peter; Joshua Kim; Sonam Popli; Brent Veerman; Jessica Saul-McBeth; Heather Conti; Shondra M Pruett-Miller; Saurabh Chattopadhyay; Ritu Chakravarti
Journal:  Proc Natl Acad Sci U S A       Date:  2020-09-23       Impact factor: 11.205

4.  Aortitis in COVID-19.

Authors:  Pravash Dhakal; Sushmita Khadka; Jackie A Clowes; Raja Chandra Chakinala
Journal:  IDCases       Date:  2021-03-10

5.  Granulocyte colony-stimulating factor associated arteritis in a patient with castration-resistant prostate cancer.

Authors:  Satoshi Nitta; Takazo Tanaka; Ryota Yanagihashi; Haruna Nonaka; Shuhei Suzuki; Tomokazu Kimura; Shuya Kandori; Akio Hoshi; Hiromitsu Negoro; Hiroyuki Nishiyama
Journal:  IJU Case Rep       Date:  2021-09-21

6.  Carbon Monoxide-Releasing Molecule-2 Ameliorates Particulate Matter-Induced Aorta Inflammation via Toll-Like Receptor/NADPH Oxidase/ROS/NF-κB/IL-6 Inhibition.

Authors:  Thi Thuy Tien Vo; Chien-Yi Hsu; Yinshen Wee; Yuh-Lien Chen; Hsin-Chung Cheng; Ching-Zong Wu; Wei-Ning Lin; I-Ta Lee
Journal:  Oxid Med Cell Longev       Date:  2021-07-13       Impact factor: 6.543

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.